Videndum (VID) Trading Update summary
Event summary combining transcript, slides, and related documents.
Trading Update summary
13 Jun, 2025Financial performance and trading update
First half 2024 revenue was broadly in line with expectations, with some post-strike recovery in the cine and scripted TV market, though recovery is slower than anticipated.
Net debt at 30 June 2024 was approximately £118 million, down from £122.4 million at 31 March 2024.
Macroeconomic challenges persist in consumer and independent content creator segments, prompting continued focus on cost, capex, and working capital control.
Broadcast TV segment continues to perform well, with second half performance expected to benefit from the Summer 2024 Olympic Games and the US Presidential election.
Board expects a gradual recovery in the second half of FY 2024, but the pace and shape of post-strike recovery remain uncertain.
Liquidity and capital structure
Committed Revolving Credit Facility (RCF) has been renegotiated: extended, reduced in quantum, and lending covenants relaxed.
RCF amendments preclude dividend declaration until delivery of the 31 March 2025 covenant test.
Total committed facility reduced by £50 million to £150 million, reflecting lower borrowings after the December 2023 equity raise.
Termination date of the RCF extended by six months to 14 August 2026.
Lending covenants for leverage and interest cover have been amended for 2024 and will continue to be tested quarterly.
Outlook and upcoming events
Interim results for the six months ending 30 June 2024 are expected to be released in late September 2024.
Second half performance anticipated to improve with major global events and gradual market recovery.
Continued focus on cost discipline and operational efficiency amid ongoing market uncertainty.
Latest events from Videndum
- Revenue down 7% year-over-year, but cash flow and cost controls support a 2025 recovery.VID
H1 202420 Jan 2026 - Revenue down 8% and £147m loss, but cost savings and refinancing support future recovery.VID
H2 202428 Nov 2025 - Revenue down 25% YoY; cost savings and new products support recovery amid uncertainty.VID
H1 202523 Nov 2025 - Order intake and EBITDA improved in Q3, with deleveraging talks and FY26 outlook steady.VID
Trading Update16 Oct 2025 - FY24 revenue to reach £280m amid restructuring, with market recovery expected in H1 FY25.VID
Trading Update13 Jun 2025 - FY24 results in line; restructuring and cost savings position Videndum for recovery.VID
Trading Update6 Jun 2025